Cornea Research Foundation of America

12/10/2025

First and ONLY Treatment for Dry Age Related Macular Degeneration!

For decades, those with dry age-related macular degeneration (AMD)—which comprises 90% of all AMD—had no treatment options. That changed in late 2024 when the FDA approved a new light-based therapy requiring no injections, medications, or eye drops. Some patients improved, some stabilized, and some declined, but outcomes were significantly better than in the placebo group.

Dry AMD comes on gradually and causes a distorted, blurry, or faded area in the central vison. It causes progressively worsening vision where reading fine print or recognizing faces can be challenging. We will be tracking patients who qualify for the approved treatment, as well as those who fall outside the eligibility window just as we have done for corneal transplantation. Our cornea transplant database now houses long-term data collection on nearly 15,000 cornea transplants performed at Price Vision Group. This work will help provide desperately needed clarity about who benefits most from this innovative therapy and offer the first-ever treatment for this debilitating disease

As we found when we pioneered the new transplant techniques, DSEK and DMEK, it will take time to spread awareness about this new therapy and delaying treatment could result in more vision decline. If you or someone you know has received a dry AMD diagnosis and would like to discuss more, please contact Price Vision Group at 317-844-5530.

12/04/2025

12/02/2025

Over the last week we have celebrated people critical to cornea transplant success including study patients, eye banks, surgeons, families and caregivers and more... and today, on , we recognize our donors. If you aren't already in this group, we ask that you consider joining us with a gift of $10, $25, or even $100 to help us fuel research into 2026.

Each gift powers projects to improve transplant outcomes and expand treatments available to patients and their loved ones. Every breakthrough we celebrate, every person with restored vision, every family who gets to share in those miraculous first clear moments after surgery—our donors are front and center in their story. Thank you, donor friends!

Since 1988, people experiencing cornea problems have faithfully supported the work of CRFA to make it better for the next person and in gratitude for restored sight. Over time, we have continued to show that those investments fuel results. From pioneering small incision transplants to being the highest volume transplant center in the U.S., partnered with Price Vision Group, we now look toward the future and are embracing a number of new potential treatments to improve the vision and life styles of those with eye disease.

Because of giving back, CRFA can now fund early-stage research, while supporting continued innovation in surgical techniques, advancing work that helps donor corneas stay healthy both before and after transplant, and provide education to doctors and people across the world. Your gift makes sight possible!

Make a Giving Tuesday gift (Link in first comment or visit Cornea.org.)

Be sure to like or follow the CRFA page to stay current on what's next.

Thank you for believing in this work and for helping restore sight for patients and families around the world.

12/01/2025

Today, we honor the families and caregivers of cornea transplant recipients—the people who quietly stand beside you on your sight-restoration journey.

They are there long before surgery ever begins—

• supporting you as you process a life-changing diagnosis

• researching disease prognosis and treatment options

• talking with relatives to understand family history

• helping navigate fears, uncertainty, and even timing and logistics of when to move forward with a transplant

They sit beside you during appointments, listen closely to options, ask questions you may not have thought of, and offer the reassurance that you are not alone.

When recovery begins, they step up even more—

• ensuring you are comfortable after surgery as you spend hours resting and lying flat to help the graft take

• preparing meals and keeping things tidy so you are safe

• managing medications and your eye drop schedule to ease your burden

• even rearranging their own schedules around your post-op visits

If all of that isn't enough, they provide reassurances when the vision is still blurry and worry creeps in... and when the vision begins to clear—subtly at first—they’re right there celebrating with you. With each measured improvement on the eye chart, each clearer, brighter morning, and with each return of independence… they share your fears and joys right along with you.

Leave a comment below to thank the person(s) who supported you through your surgery and recovery. If they're on Facebook, tag them so we can honor them, too!

If you'd like to make a gift in their honor for Giving Tuesday, we will send them a card acknowledging your gift in their name. We invite you to do so by writing in their info using the additional comments box on our giving form: https://app.etapestry.com/onlineforms/CorneaResearch/givingtues.html

12/01/2025

Leading up to , we continue recognizing the many parties involved in restoring sight. Today, we honor the surgeons and eye care professionals around the world who dedicate their lives to preserving sight.

CRFA and our founder, Dr. Price of Price Vision Group, was instrumental in pioneering Descemet Membrane Endothelial Keratoplasty (DMEK), a technique that has transformed corneal transplantation. More than 800 surgeons from around the world have invested the time to train with us in Indianapolis, learning advanced procedures, and bringing life-changing skills back to their patients. Many patients still opt to travel to Centers of Excellence like Price Vision, but for those that cannot, the willingness of their surgeons to travel opens access to newer, safer treatments.

Because of their dedication and willingness to embrace innovation, DMEK recently became the most common cornea transplant technique worldwide, offering clearer vision, faster recovery, and stronger long-term outcomes (which we continue to track).

Help us celebrate your surgeons and eye care professionals —share a message of thanks or encouragement in the comments below. Your words mean more than you know to the people who make sight restoration possible, and provide hope to those still facing surgery.

11/27/2025

Behind every discovery are people who selflessly say “yes” to participating in research. Often this commitment involves extra or extended clinic visits, applying eye drops, keeping track of changes and more, and they do it to help improve available treatments for those that come after.

Today, we honor and thank the patients and volunteers who contribute to clinical studies, including landmark work like the recently completed DEKS study, which is expanding the donor pool worldwide (see below). Their willingness to participate moves science forward and brings hope to future patients.

We also recognize the many research collaborators that partner on larger studies like this to collect gather data from sites across th U.S., or even globally. We also collaborate with many universities and drug and device manufacturers to evaluate new products.Price Vision Groupthelial Keratoplasty (DEKS) Study

This study followed 1,097 DMEK patients across 28 clinical sites with 46 surgeons and corneas from 13 eye banks.

Price Vision Group was the top enrolling site.
CRFA's Executive Director, Marianne Price, was the study co-chair.

After one year, transplant success rates were similarly high with corneas from donors with and without diabetes.

In addition, endothelial cell loss was the same (28%) with corneas from donors with and without diabetes at 1 year, suggesting that the vital endothelial cell layer was equally healthy regardless of donor diabetes status.

Why this matters? These findings significantly expand the global donor pool, giving thousands more patients the opportunity for restored vision annually.


We are grateful for every participant who helps transform questions into answers.

11/26/2025

This week leading up to , we’re honoring those who make breakthroughs possible — and today we recognize the families who choose to share the gift of sight through tissue donation so others may see.

Their selfless gift and our kind supporters allow us to:
• Make transplants safer and more successful
• Train eye surgeons across the world
• Bring hope to patients facing vision loss

We invite you to be part of what comes next. Your gratitude can become someone’s restored vision.

11/24/2025

Empowering eye care professionals with knowledge that directly and immediately impacts patient care is central to our mission.

Here's a recap of our most recent CE event in partnership with Price Vision Group!

11/24/2025

We are thankful for the thousands of transplant patients who have selflessly volunteered to participate in research to make advancements and our supporters who make it possible, so all who look may see®.

Share in the comments what you're thankful for today!

11/24/2025

11/12/2025

Choosing a cornea transplant surgeon is hard...until you find Price Vision Group in Indianapolis. All transplant patients are followed by CRFA. Research & long-term outcomes data on Cornea.org. Link in comment.